Brain Cancer

Occipital Lobe Glioblastoma

Female, 65 years

Patient Internal 7750580

ICD-10 code

C71.4 for Malignant Neoplasm of Occipital Lobe

Diagnosis (Incl. Metastases/Stage) and Year

July 2019
Glioblastoma of the Left Side of the Occipital Lobe, WHO IV.

Previous Treatment

Surgery, Radiation Therapy, Chemotherapy (Temozolomide).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of ~14 months from diagnosis.

Treatment Provided

Autologous DCV (5 doses) over a period of 2 months.

Patient Survival/Condition and Year
Date of Review: 30/12/2023

The patient has survived for 38 months since the diagnosis. It can be concluded that the addition of Immunotherapy ,alongside Surgery, Radiation Therapy and Chemotherapy, has extended patient survival by an estimate of around 24 months.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok